Literature DB >> 24424920

The ideal vaccine.

G L Ada1.   

Abstract

The ideal vaccine is discussed under three headings. 1. The major requirements of the vaccine. This includes primarlly safety and efficacy and a number of other desirable features if the vaccine is to control a disease of global importance. These include cost, easy administration (e.g. orally), thermal stability, multivalency and long-lived immunlty 2. The nature and persistence of the immune responses which, as judged by model systems, are probably generated by the most effective viral vaccines in current human usage. 3. Approaches for developing future 'simplified" vaccines with similar levels of safety and efficacy so that these objectives are achieved.

Entities:  

Year:  1991        PMID: 24424920     DOI: 10.1007/BF00328978

Source DB:  PubMed          Journal:  World J Microbiol Biotechnol        ISSN: 0959-3993            Impact factor:   3.312


  6 in total

Review 1.  The immunological principles of vaccination.

Authors:  G L Ada
Journal:  Lancet       Date:  1990-03-03       Impact factor: 79.321

2.  Phase I clinical trial of a World Health Organisation birth control vaccine.

Authors:  W R Jones; J Bradley; S J Judd; E H Denholm; R M Ing; U W Mueller; J Powell; P D Griffin; V C Stevens
Journal:  Lancet       Date:  1988-06-11       Impact factor: 79.321

Review 3.  The immune response to influenza infection.

Authors:  G L Ada; P D Jones
Journal:  Curr Top Microbiol Immunol       Date:  1986       Impact factor: 4.291

4.  Prevention of vaccinia virus infection in immunodeficient mice by vector-directed IL-2 expression.

Authors:  C Flexner; A Hügin; B Moss
Journal:  Nature       Date:  1987 Nov 19-25       Impact factor: 49.962

5.  Protection and recovery in influenza virus-infected mice immunosuppressed with anti-IgM.

Authors:  R M Kris; R Asofsky; C B Evans; P A Small
Journal:  J Immunol       Date:  1985-02       Impact factor: 5.422

6.  Recovery of immunodeficient mice from a vaccinia virus/IL-2 recombinant infection.

Authors:  I A Ramshaw; M E Andrew; S M Phillips; D B Boyle; B E Coupar
Journal:  Nature       Date:  1987 Oct 8-14       Impact factor: 49.962

  6 in total
  7 in total

1.  Moderate Heat-Assisted Gene Electrotransfer for Cutaneous Delivery of a DNA Vaccine Against Hepatitis B Virus.

Authors:  Chelsea Edelblute; Cathryn Mangiamele; Richard Heller
Journal:  Hum Gene Ther       Date:  2021-06-09       Impact factor: 5.695

Review 2.  Development and Challenges in Animal Tuberculosis Vaccination.

Authors:  Ana Balseiro; Jobin Thomas; Christian Gortázar; María A Risalde
Journal:  Pathogens       Date:  2020-06-15

Review 3.  Nanoparticle-Based Immunoengineered Approaches for Combating HIV.

Authors:  Allan Bowen; Elizabeth E Sweeney; Rohan Fernandes
Journal:  Front Immunol       Date:  2020-04-28       Impact factor: 7.561

Review 4.  Dendritic Cells/Macrophages-Targeting Feature of Ebola Glycoprotein and its Potential as Immunological Facilitator for Antiviral Vaccine Approach.

Authors:  Titus Abiola Olukitibi; Zhujun Ao; Mona Mahmoudi; Gary A Kobinger; Xiaojian Yao
Journal:  Microorganisms       Date:  2019-09-29

Review 5.  Microneedle-Based Vaccine Delivery: Review of an Emerging Technology.

Authors:  Ihab Mansoor; Heba A Eassa; Kamilia H A Mohammed; Marwa A Abd El-Fattah; Marwa H Abdo; Eman Rashad; Hadeer A Eassa; Asmaa Saleh; Omnya M Amin; Mohamed Ismail Nounou; Ola Ghoneim
Journal:  AAPS PharmSciTech       Date:  2022-04-05       Impact factor: 4.026

Review 6.  Nanoparticle Vaccines Against Infectious Diseases.

Authors:  Rashmirekha Pati; Maxim Shevtsov; Avinash Sonawane
Journal:  Front Immunol       Date:  2018-10-04       Impact factor: 7.561

Review 7.  COVID-19: Insights into Potential Vaccines.

Authors:  Ke-Yan Loo; Vengadesh Letchumanan; Hooi-Leng Ser; Siew Li Teoh; Jodi Woan-Fei Law; Loh Teng-Hern Tan; Nurul-Syakima Ab Mutalib; Kok-Gan Chan; Learn-Han Lee
Journal:  Microorganisms       Date:  2021-03-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.